Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Isoxazolidine Compounds. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115215814A details a novel Rh-catalyzed C-H activation route to isoxazolidines, offering mild conditions and broad substrate scope for reliable pharmaceutical intermediate supply.